Brief: Sedana Medical Gets Additional Year Of Market Protection For Sedaconda
Feb 4 (Reuters) - Sedana Medical AB SEDANA.ST :
* SAID ON MONDAY GETS ADDITIONAL YEAR OF MARKET PROTECTION
FOR
SEDACONDA
* EXTENSION OF PROTECTION PERIOD UNTIL 2032
Source text for Workspace: urn:newsml:reuters.com:*:nMFNFX2Rl
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln